We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Celestica
CLS
$36B
| $1.33M | ﹤0.01% |
169,954
+44,750
| +36% | +$373K |
|
|
SII
3077
Sprott
SII
$3B
| $1.33M | ﹤0.01% |
33,887
+9,791
| +41% | +$421K |
|
3078
iShares S&P 500 Value ETF
IVE
$49.8B
| $1.33M | ﹤0.01% |
+9,000
| New | +$1.33M |
|
|
KRTX
3079
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.33M | ﹤0.01% |
11,656
-4,373
| -27% | -$511K |
|
3080
Cal-Maine
CALM
$3.99B
| $1.33M | ﹤0.01% |
36,667
-8,799
| -19% | -$329K |
|
|
SFIX
3081
PUT
Stitch Fix
SFIX
$562M
| $1.33M | ﹤0.01% |
22,000
-8,300
| -27% | -$425K |
|
|
BBT
3082
Beacon Financial Corp
BBT
$2.67B
| $1.32M | ﹤0.01% |
48,495
+3,017
| +7% | +$76.6K |
|
3083
Hyliion Holdings
HYLN
$719M
| $1.32M | ﹤0.01% |
111,963
+73,116
| +188% | +$765K |
|
3084
Camtek
CAMT
$7.34B
| $1.32M | ﹤0.01% |
35,035
+4,260
| +14% | +$145K |
|
3085
MacroGenics
MGNX
$252M
| $1.32M | ﹤0.01% |
49,245
+2,963
| +6% | +$86.8K |
|
|
GES
3086
DELISTED
Guess Inc
GES
| $1.32M | ﹤0.01% |
51,627
-57,502
| -53% | -$1.59M |
|
3087
The Greenbrier Companies
GBX
$1.45B
| $1.32M | ﹤0.01% |
30,853
-50,921
| -62% | -$2.35M |
|
|
RDUS
3088
DELISTED
Radius Health, Inc.
RDUS
| $1.32M | ﹤0.01% |
72,207
+1,879
| +3% | +$37.4K |
|
|
CBD
3089
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $1.31M | ﹤0.01% |
+167,952
| New | +$1.2M |
|
|
VAPO
3090
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $1.31M | ﹤0.01% |
6,787
-8,917
| -57% | -$1.52M |
|
|
WIRE
3091
DELISTED
Encore Wire Corp
WIRE
| $1.31M | ﹤0.01% |
17,283
-747
| -4% | -$57.5K |
|
3092
Dillards
DDS
$9.62B
| $1.31M | ﹤0.01% |
7,369
-8,734
| -54% | -$1.13M |
|
3093
Interface
TILE
$2.29B
| $1.3M | ﹤0.01% |
85,229
+15,934
| +23% | +$229K |
|
|
ELAT
3094
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $1.3M | ﹤0.01% |
+24,000
| New | +$1.2M |
|
3095
Vanda Pharmaceuticals
VNDA
$305M
| $1.3M | ﹤0.01% |
60,568
-6,318
| -9% | -$113K |
|
3096
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.69B
| $1.3M | ﹤0.01% |
+15,000
| New | +$1.27M |
|
3097
First Bancorp
FBNC
$2.66B
| $1.29M | ﹤0.01% |
31,645
+271
| +0.9% | +$11.7K |
|
3098
CALL
PVH
PVH
$4.01B
| $1.29M | ﹤0.01% |
12,300
-10,600
| -46% | -$1.16M |
|
|
ICPT
3099
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.29M | ﹤0.01% |
64,685
-19,986
| -24% | -$396K |
|
3100
IAMGOLD
IAG
$10.4B
| $1.29M | ﹤0.01% |
436,866
-61,470
| -12% | -$207K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.